Skip to main content

CV Sciences, Inc.

CVSI
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001510964

In the last 90 days, CV Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysLast 90 days, $114.8K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding CVSI, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CVSI at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by CV Sciences, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 9, 2026 (view filing)6:43 PM ETJul 16-Aug 755 daysLateCheever Charlie E III10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+5.74M$0.02+$114.8K+27.5%26.6M after10 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in CV Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding CVSI in 13F filings for Q2 2026.